News
TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, enabled researchers at Hospital Quir?nsalud Marbella and Hospital
Read more...Getinge announces today an agreement to acquire 100% of the shares in High Purity New England, Inc. a leading US-based company in the fast-growing areas of custom single-use
Read more...VieCure, a cancer care company with a market-leading artificial intelligence, informatics, and clinical decision support platform, announced today a new strategic collaboration with Clarified
Read more...Cellular Origins, a TTP Company focused on enabling scalable, cost-effective and space-efficient manufacture of cell and gene therapies, has today announced the launch of Constellation
Read more...GE HealthCare today announced US FDA 510(k) clearance of Precision DL ? a new, revolutionary deep learning-based image processing software included in GE HealthCare?s growing Effortless
Read more...Takeda and HUTCHMED Limited today announced that the U.S. Food and Drug Administration has granted priority review of the New Drug Application (NDA) for fruquintinib, a highly selective
Read more...FivepHusion, an advanced clinical-stage biotechnology company, today announced its collaboration with Treehill Partners, a New York-based strategic and financial advisory firm
Read more...Synapse Medicine, the leader in medication success, and CompuGroup Medical, the leader in software for providers, have announced a partnership to accelerate innovation in prescribing
Read more...25 May 2023
IQVIA? a leading global provider of advanced analytics, technology solutions, and clinical research services to the life science industry, announced a groundbreaking partnership today
Read more...Celltrion USA today announced that the U.S. Food and Drug Administration has approved Yuflyma, a high-concentration and citrate-free formulation of Humira? (adalimumab) biosimilar.
Read more...